Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · Real-Time Price · USD
3.470
-0.110 (-3.07%)
Feb 21, 2025, 4:00 PM EST - Market closed
Third Harmonic Bio Market Cap
Third Harmonic Bio has a market cap or net worth of $156.35 million as of February 21, 2025. Its market cap has decreased by -57.71% in one year.
Market Cap
156.35M
Enterprise Value
-136.34M
1-Year Change
-57.71%
Ranking
Category
Stock Price
$3.47
Market Cap Chart
Since the IPO on September 15, 2022, Third Harmonic Bio's market cap has decreased from $657.80M to $156.35M, a decrease of -76.23%. That is a compound annual growth rate of -44.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 156.35M | -66.28% |
| Dec 31, 2024 | 463.65M | 4.71% |
| Dec 29, 2023 | 442.78M | 153.97% |
| Dec 30, 2022 | 174.34M | -73.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 780.72B |
| UnitedHealth Group | 470.30B |
| Johnson & Johnson | 380.14B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.39B |
| Abbott Laboratories | 229.17B |
| AstraZeneca | 228.16B |
| Intuitive Surgical | 217.02B |